Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines

Clinical and Developmental Immunology

Volumn 2008, Issue , 2008, Pages

  Klein Klouwenberg, Peter ^a   Bont, Louis ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIAL VACCINE; COMPLEMENT COMPONENT C3D RECEPTOR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; NEISSERIA MENINGITIDIS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG; COMPLEMENT; CYTOKINE; THYMUS INDEPENDENT ANTIGEN; VACCINE;

B LYMPHOCYTE; BRONCHITIS; EPIGLOTTITIS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFANT; MENINGITIS; MENINGOCOCCOSIS; NEWBORN; NONHUMAN; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SINUSITIS; T LYMPHOCYTE; IMMUNOLOGY; LYMPHOCYTE;

ANTIGENS, T-INDEPENDENT; BACTERIAL VACCINES; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOCYTES; POLYSACCHARIDES, BACTERIAL; RECEPTORS, COMPLEMENT 3D; VACCINES, CONJUGATE;

EID: 54249087150     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2008/628963     Document Type: Review

References (98)

1. World Health Organization, Maternal Health and Safe Motherhood Programme. MSM96.7, 1996
2. The WHO Young Infants Study Group, Conclusions from the WHO multicenter study of serious infections in young infants Pediatric Infectious Disease Journal 1999 18 10, supplement S32 S34
3. Thomas-Rudolph D., Du Clos T. W., Snapper C. M., Mold C., C-reactive protein enhances immunity to Streptococcus pneumonia e by targeting uptake to Fc γ R on dendritic cells The Journal of Immunology 2007 178 11 7283 7291
4. Jakobsen H., Hannesdottir S., Bjarnarson S. P., Early life T Cell responses to pneumucoccal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy European Journal of Immunology 2006 36 2 287 295
5. Rijkers G. T., Sanders E. A. M., Breukels M. A., Zegers B. J. M., Infant B cell responses to polysaccharide determinants Vaccine 1998 16 14-15 1396 1400
6. Bondada S., Wu H.-J., Robertson D. A., Chelvarajan R. L., Accessory cell defect in unresponsiveness of neonates and aged to polysaccharide vaccines Vaccine 2000 19 4-5 557 565
7. Mosier D. E., Mond J. J., Goldings E. A., The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect The Journal of Immunology 1977 119 6 1874 1878
8. Mond J. J., Lees A., Snapper C. M., T cell-independent antigens type 2 Annual Review of Immunology 1995 13 1 655 692
9. Mond J. J., Vos Q., Lees A., Snapper C. M., T cell independent antigens Current Opinion in Immunology 1995 7 3 349 354
10. Yan S. R., Byers D. M., Bortolussi R., Role of protein tyrosine kinase p53/56lyn in diminished lipopolysaccharide priming of formylmethionylleucyl- phenylalanine-induced superoxide production in human newborn neutrophils Infection and Immunity 2004 72 11 6455 6462
11. Levy O., Sisson R. B., Kenyon J., Eichenwald E., Macone A. B., Goldmann D., Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo Infection and Immunity 2000 68 9 5120 5125
12. Rijkers G. T., Sanders L. A. M., Zegers B. J. M., Anti-capsular polysaccharide antibody deficiency states Immunodeficiency 1993 5 1 1 21
13. Wright P. F., Wright P. F., Infectious diseases in early life in industrialized countries Vaccine 1998 16 14-15 1355 1359
14. Kovarik J., Siegrist C.-A., Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators Immunology & Cell Biology 1998 76 3 222 236
15. Pihlgren M., Friedli M., Tougne C., Rochat A.-F., Lambert P.-H., Siegrist C.-A., Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival The Journal of Immunology 2006 176 1 165 172
16. Trotter C. L., Andrews N. J., Kaczmarski E. B., Miller E., Ramsay M. E., Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction The Lancet 2004 364 9431 365 367
17. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S., Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response The Journal of Immunology 1989 143 10 3200 3206
18. Zegers B. J. M., Van Der Giessen M., Reerink-Brongers E. E., Stoop J. W., The serum IgG subclass levels in healthy infants of 13-62 weeks of age Clinica Chimica Acta 1980 101 2-3 265 269
19. Kutukculer N., Karaca N. E., Demircioglu O., Aksu G., Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency Pediatric Allergy and Immunology 2007 18 2 167 173
20. Barrett D. J., Ayoub E. M., IgG2 subclass restriction of antibody to pneumococcal polysaccharides Clinical and Experimental Immunology 1986 63 1 127 134
21. Castagnola E., Fioredda F., Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes European Journal of Haematology 2003 71 5 319 326
22. Adamkiewicz T. V., Silk B. J., Howgate J., Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life Pediatrics 2008 121 3 562 569
23. Mosier D. E., Zitron I. M., Mond J. J., Ahmed A., Scher I., Paul W. E., Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes Immunological Reviews 1977 37 1 89 104
24. Balogh P., Aydar Y., Tew J. G., Szakal A. K., Ontogeny of the follicular dendritic cell phenotype and function in the postnatal murine spleen Cellular Immunology 2001 214 1 45 53
25. Lanoue A., Clatworthy M. R., Smith P., SIGN-R1 contributes to protection against lethal pneumococcal infection in mice Journal of Experimental Medicine 2004 200 11 1383 1393
26. Koppel E. A., Litjens M., van den Berg V. C., van Kooyk Y., Geijtenbeek T. B. H., Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae Molecular Immunology 2008 45 10 2881 2887
27. Llopis M.-J.P., Harms G., Hardonk M. J., Timens W., Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells Journal of Allergy and Clinical Immunology 1996 97 4 1015 1024
28. Griffioen A. W., Franklin S. W., Zegers B. J. M., Rijkers G. T., Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes Clinical Immunology and Immunopathology 1993 69 1 1 8
29. Davis C. A., Vallota E. H., Forristal J., Serum complement levels in infancy: age related changes Pediatric Research 1979 13 9 1043 1046
30. Breukels M. A., Zandvoort A., Rijkers G. T., Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines Scandinavian Journal of Immunology 2005 61 4 322 328
31. Kobrynski L. J., Sousa A. O., Nahmias A. J., Lee F. K., Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ cells The Journal of Immunology 2005 174 4 1787 1790
32. Chelvarajan R. L., Gilbert N. L., Bondada S., Neonatal murine B lymphocytes respond to polysaccharide antigens in the presence of IL-1 and IL-6 The Journal of Immunology 1998 161 7 3315 3324
33. Angelone D. F., Wessels M. R., Coughlin M., Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF- α production in vitro and in vivo Pediatric Research 2006 60 2 205 209
34. Chelvarajan R. L., Collins S. M., Doubinskaia I. E., Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens Journal of Leukocyte Biology 2004 75 6 982 994
35. Chelvarajan L., Popa D., Liu Y., Getchell T. V., Stromberg A. J., Bondada S., Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages Journal of Leukocyte Biology 2007 82 2 403 416
36. Nossal G. J., Cellular mechanisms of immunologic tolerance Annual Review of Immunology 1983 1 1 33 62
37. Kurikka S., Käyhty H., Saarinen L., Ronnberg P.-R., Eskola J., Makela P. H., Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy The Journal of Infectious Diseases 1995 172 5 1268 1272
38. Eskola J., Käyhty H., Early immunization with conjugate vaccines Vaccine 1998 16 14-15 1433 1438
39. Eskola J., Ward J., Dagan R., Goldblatt D., Zepp F., Siegrist C.-A., Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis The Lancet 1999 354 9195 2063 2068
40. Adkins B., Leclerc C., Marshall-Clarke S., Neonatal adaptive immunity comes of age Nature Reviews Immunology 2004 4 7 553 564
41. Bjarnarson S. P., Jakobsen H., Del Giudice G., Trannoy E., Siegrist C.-A., Jonsdottir I., The advantage of mucosal immunization for polysaccharide-specific memory responses in early life European Journal of Immunology 2005 35 4 1037 1045
42. Booy R., Heath P. T., Slack P. E. M., Begg N., Moxon E. R., Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster The Lancet 1997 349 9060 1197 1202
43. Ribeiro G. S., Lima J. B. T., Reis J. N., Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil Vaccine 2007 25 22 4420 4428
44. Barbour M. L., Mayon-White R. T., Coles C., Crook D. W. M., Moxon E. R., The impact of conjugate vaccine on carriage of Haemophilus influenzae type b The Journal of Infectious Diseases 1995 171 1 93 98
45. Mäkelä P. H., Peltola H., Käyhty H., Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland The Journal of Infectious Diseases 1977 136 supplement S43 S50
46. Peltola H., Meningococcal vaccines. Current status and future possibilities Drugs 1998 55 3 347 366
47. Conterno L. O., Silva Filho C. R., Rüggeberg J. U., Heath P. T., Conjugate vaccines for preventing meningococcal C meningitis and septicaemia Cochrane Database of Systematic Reviews 2006 3
48. Larrauri A., Cano R., García M., de Mateo S., Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain Vaccine 2005 23 32 4097 4100
49. Findlow J., Taylor S., Aase A., Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac Infection and Immunity 2006 74 8 4557 4565
50. Nókleby H., Aavitsland P., O'Hallahan J., Feiring B., Tilman S., Oster P., Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease Vaccine 2007 25 16 3080 3084
51. Demachy M.-C., Vernet-Garnier V., Cottin J., Antimicrobial resistance data on 16,756 Streptococcus pneumoniae isolates in 1999: a pan-regional multicenter surveillance study in France Microbial Drug Resistance 2005 11 4 323 329
52. Lesinski G. B., Westerink M. A., Vaccines against polysaccharide antigens Current Drug Targets - Infectious Disorders 2001 1 3 325 334
53. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper Weekly Epidemiological Record 2007 82 12 93 104
54. Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children. April 2008, http://www.clinicaltrials. gov/
55. Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-Valent Pneumococcal Conjugate Vaccine. April 2008, http://www.clinicaltrials. gov/
56. Black S., Shinefield H., Fireman B., Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Pediatric Infectious Disease Journal 2000 19 3 187 195
57. Grijalva C. G., Nuorti J. P., Arbogast P. G., Martin S. W., Edwards K. M., Griffin M. R., Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis The Lancet 2007 369 9568 1179 1186
58. Tsai C. J., Griffin M. R., Nuorti J. P., Grijalva C. G., Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States Clinical Infectious Diseases 2008 46 11 1664 1672
59. Eskola J., Kilpi T., Palmu A., Efficacy of a pneumococcal conjugate vaccine against acute otitis media The New England Journal of Medicine 2001 344 6 403 409
60. Michon F., Uitz C., Sarkar A., Group B streptococcal type II and III conjugate vaccines: physicochemical properties that influence immunogenicity Clinical and Vaccine Immunology 2006 13 8 936 943
61. Lin F. Y. C., Ho V. A., Khiem H. B., The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children The New England Journal of Medicine 2001 344 17 1263 1269
62. Cryz S. J. Jr., Que J. O., Cross A. S., Fürer E., Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine Vaccine 1995 13 5 449 453
63. Tollersrud T., Zernichow L., Andersen S. R., Kenny K., Lund A., Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle Vaccine 2001 19 28-29 3896 3903
64. Singleton R. J., Hennessy T. W., Bulkow L. R., Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage The Journal of the American Medical Association 2007 297 16 1784 1792
65. Eskola J., Peltola H., Takala A. K., Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy The New England Journal of Medicine 1987 317 12 717 722
66. Kelly D. F., Moxon E. R., Pollard A. J., Haemophilus influenzae type b conjugate vaccines Immunology 2004 113 2 163 174
67. Yeh C. L., Kelly D. F., Yu L.-M., Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody Clinical Infectious Diseases 2008 46 2 186 192
68. McVernon J., Andrews N., Slack M. P. E., Ramsay M. E., Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis The Lancet 2003 361 9368 1521 1523
69. Kitchin N. R. E., Southern J., Morris R., Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus- Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age Archives of Disease in Childhood 2007 92 1 11 16
70. Schmitt H.-J., Maechler G., Habermehl P., Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine Clinical and Vaccine Immunology 2007 14 4 426 434
71. Gatchalian S., Palestroque E., De Vleeschauwer I., The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B- Haemophilus influenzae type b- Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components International Journal of Infectious Diseases 2008 12 3 278 288
72. Vidor E., Hoffenbach A., Fletcher M. A., Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses Current Medical Research and Opinion 2001 17 3 197 209
73. Wyle F. A., Artenstein M. S., Brandt B. L., Immunologic response of man to group B meningococcal polysaccharide vaccines The Journal of Infectious Diseases 1972 126 5 514 521
74. Devi S. J. N., Zollinger W. D., Snoy P. J., Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys Infection and Immunity 1997 65 3 1045 1052
75. Auckland C., Gray S., Borrow R., Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom The Journal of Infectious Diseases 2006 194 12 1745 1752
76. Blanchard Rohner G., Snape M. D., Kelly D. F., The magnitude of the antibody and memory B cell responses during priming with a protein- polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response The Journal of Immunology 2008 180 4 2165 2173
77. Tichmann-Schumann I., Soemantri P., Behre U., Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus- Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine Pediatric Infectious Disease Journal 2005 24 1 70 77
78. Kyaw M. H., Lynfield R., Schaffner W., Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae The New England Journal of Medicine 2006 354 14 1455 1463
79. Veenhoven R., Bogaert D., Uiterwaal C., Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study The Lancet 2003 361 9376 2189 2195
80. Bernatoniene J., Finn A., Advances in pneumococcal vaccines advantages for infants and children Drugs 2005 65 2 229 255
81. Nieminen T., Eskola J., Käyhty H., Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum Vaccine 1998 16 6 630 636
82. Nurkka A., Ahman H., Korkeila M., Jantti V., Käyhty H., Eskola J., Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine Pediatric Infectious Disease Journal 2001 20 1 25 33
83. Marchant A., Newport M., Prevention of infectious disease by neonatal and early infantile immunization: prospects for the new millennium Current Opinion in Infectious Diseases 2000 13 3 241 246
84. Cohen N., Stolarsky-Bennun M., Amir-Kroll H., Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive The Journal of Immunology 2008 180 4 2409 2418
85. Levy O., Suter E. E., Miller R. L., Wessels M. R., Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells Blood 2006 108 4 1284 1290
86. Chu R. S., Mccool T., Greenspan N. S., Schreiber J. R., Harding C. V., CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide- protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies Infection and Immunity 2000 68 3 1450 1456
87. Konen-Waisman S., Fridkin M., Cohen I. R., Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen The Journal of Immunology 1995 154 11 5977 5985
88. Amir-Kroll H., Riveron L., Sarmiento M. E., Sierra G., Acosta A., Cohen I. R., A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide Vaccine 2006 24 42-43 6555 6563
89. Jakobsen H., Bjarnarson S., Del Giudice G., Moreau M., Siegrist C.-A., Jonsdottir I., Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice Infection and Immunity 2002 70 3 1443 1452
90. Baudner B. C., Verhoef J. C., Giuliani M. M., Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform Journal of Drug Targeting 2005 13 8-9 489 498
91. Sabirov A., Metzger D. W., Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media Vaccine 2006 24 27-28 5584 5592
92. De Magistris M. T., Mucosal delivery of vaccine antigens and its advantages in pediatrics Advanced Drug Delivery Reviews 2006 58 1 52 67
93. Rapola S., Jantti V., Haikala R., Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media The Journal of Infectious Diseases 2000 182 4 1146 1152
94. Virolainen A., Russell W., Crain M. J., Rapola S., Käyhty H., Briles D. E., Human antibodies to pneumococcal surface protein A in health and disease Pediatric Infectious Disease Journal 2000 19 2 134 138
95. Morrison K. E., Lake D., Crook J., Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis Journal of Clinical Microbiology 2000 38 1 434 437
96. Lawrence M. C., Pilling P. A., Epa V. C., Berry A. M., Ogunniyi A. D., Paton J. C., The crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein Structure 1998 6 12 1553 1561
97. Weintraub A., Immunology of bacterial polysaccharide antigens Carbohydrate Research 2003 338 23 2539 2547
98. Kieber-Emmons T., Monzavi-Karbassi B., Wang B., Luo P., Weiner D. B., Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response The Journal of Immunology 2000 165 2 623 627